Comparison of Plasma Profiles of Lovastatin (Mevinolin), Simvastatin (Epistatin) and Pravastatin (Eptastatin) in the Dog
- 1 January 1990
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 2 (S2) , 18-28
- https://doi.org/10.1007/bf03258190
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantationThe American Journal of Medicine, 1989
- Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemiaThe American Journal of Cardiology, 1987
- Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductaseJournal of Medicinal Chemistry, 1985
- Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1984
- Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.Proceedings of the National Academy of Sciences, 1983
- Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.Journal of Clinical Investigation, 1982
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980